Pfizer plans to seek Emergency Use Authorization (EUA) for an antiviral Covid-19 treatment following an interim analysis of Phase II/III data shown to be statistically and...
An oral antiviral drug developed by Pfizer has been shown to dramatically cut the risk of hospitalisation or The post Pfizer’s pill cuts COVID deaths and...
Merck & Co and Ridgeback’s oral antiviral molnupiravir has been approved in its first market – the UK The post UK first to authorise Merck/Ridgeback’s COVID...
A generic pill has been shown to reduce hospitalisation rates in high-risk patients with early COVID-19, potentially offering The post Generic pill could be alternative to...
The EMA has started a rolling review of Merck & Co and Ridgeback Biotherapeutics’ much-anticipated oral antiviral molnupiravir The post EU starts review of Merck’s oral...
Merck has submitted data to the U.S. Food and Drug Administration for Emergency Use Authorization (EUA) for the company's antiviral pill molnupiravir.
Pfizer Launches Final Study For COVID Drug That's Suspiciously Similar To 'Horse Paste' Another piece US anti-Ivermectin puzzle may have emerged. On Monday, Pfizer announced that...
Pfizer Inc. started a large study testing the company's investigational oral antiviral drug for the prevention of Covid-19 infection among those who have been exposed to...
Check out these health care stocks making headlines in the stock market now. The post 4 Top Health Care Stocks To Watch Now Ahead Of Debt...
Pfizer Inc. started dosing in a mid-to-late-stage trial of the company's oral antiviral therapy for Covid-19 in non-hospitalized, symptomatic adult patients.
The World Health Organization (WHO) said on Aug. 11 a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for Covid-19 patients.
Review of the life histories of RNA viruses, their genetics, and the compounds that could disrupt them offers hope for curtailment of future pandemics Credit: Illustration:...
Combination was uncovered from examining 12 potential drug candidates with over 530,0000 possible drug combinations within two weeks Credit: National University of Singapore A team of...
Initial studies suggest these drugs, widely taken to lower cholesterol, may also reduce the severity of COVID-19.
Will test a number of promising treatments in urgently needed focus on mild and moderate cases Credit: Kenny Mbala-DNDi NAIROBI/KINSHASA/GENEVA – 24 NOVEMBER 2020 Thirteen African...
Lilly’s baricitinib granted US emergency use in COVID-19
Roche’s Actemra helps sickest Covid-19 patients, study shows
The ‘failure’ of clinical trials in the search for COVID-19 treatments
Convalescent plasma misses the mark in phase 2 trial
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
EU makes 1 billion euro bet on Gilead’s Covid drug before trial results
Trump’s Treatments: Regeneron’s Antibodies and Gilead’s Remdesivir Explained
Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial
Certara adds to its COVID-19 toolkit with virtual trials module
Basel study: Why lopinavir and hydroxychloroquine do not work on COVID-19
Which drugs and therapies are proven to work, and which ones don't, for COVID-19?
3 "Strong Buy" Coronavirus Stocks With Massive Upside Potential
UK team awarded grant for ‘second wave’ COVID-19 drug hunt
Futures Spike After Study Reveals Steroid Effective Against Advanced COVID-19